Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | GSK3B | P49841 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | APLNR | P35414 | 1/20 | 0.40 |
| ▸ | PFKFB3 | Q16875 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | MAOB | P27338 | 1/20 | 0.39 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.38 |
| ▸ | FKBP5 | Q13451 | 1/20 | 0.38 |
| ▸ | QPCT | Q16769 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | CYP1A1 | P04798 | 3/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29661780 | 1.00 | MEN1 (0.41) | MEN1KMT2ANPC1RAB9AGSK3B | |
| SCHEMBL29703392 | 0.82 | APLNR (0.39) | ALDH1A1KDM4EAPLNRMAOBCYP1A2 | |
| SCHEMBL22865430 | 0.82 | APLNR (0.39) | ALDH1A1KDM4EAPLNRMAOBCYP1A2 | |
| SCHEMBL23133 | 0.76 | NPC1 (0.57) | MEN1KMT2ANPC1RAB9AALDH1A1 | |
| Bromide SCHEMBL1193036 | 0.74 | NPC1 (0.56) | MEN1KMT2ANPC1RAB9AALDH1A1 | |
| SCHEMBL9016292 | 0.69 | TAS1R3 (0.43) | MEN1KMT2ANPC1RAB9AALDH1A1 | |
| SCHEMBL10384501 | 0.69 | RAB9A (0.44) | MEN1KMT2ANPC1RAB9AGSK3B | |
| SCHEMBL28029839 | 0.68 | APLNR (0.61) | ALDH1A1APLNRCYP1A1CYP1A2CYP1B1 | |
| SCHEMBL29992983 | 0.68 | NPC1 (0.56) | MEN1KMT2ANPC1RAB9AALDH1A1 | |
| Toluene SCHEMBL11239856 | 0.67 | ALDH1A1 (0.49) | MEN1KMT2ANPC1RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230014870-A1 | NOVEL GALACTOSIDE INHIBITOR OF GALECTINS | GALECTO BIOTECH AB (DK) | 2023-01-19 | — | — | US | disclosed |
| CN-114555620-A | Novel galactoside inhibitors of galectins | 格莱克特生物技术公司 | 2022-05-27 | — | — | CN | disclosed |
| WO-2021001528-A1 | NOVEL GALACTOSIDE INHIBITOR OF GALECTINS | GALECTO BIOTECH AB (SE) | 2021-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230014870-A1 | NOVEL GALACTOSIDE INHIBITOR OF GALECTINS | LGALS1, LGALS3, LGALS2 | MEN1 2935/4885KMT2A 4762/4885NPC1 2659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.